Uncategorized

Nov 15, 2024

Jorge Piedrahita Stepping Down as Co-Director

Dear Colleagues, After almost ten years of serving as the Director or co-Director of the Comparative Medicine Institute, I have made the decision to step down from this position effective June 30, 2025. It has been an incredible journey filled with meaningful accomplishments, and I am fully confident that I leave the CMI well-positioned for… 

Nov 4, 2024

CMI 2024 Magazine Now Available

CMI’s annual magazine is now available! Read about our strategic reorganization, exciting new discoveries, funding opportunities, and student accomplishments from the past academic year. 

Oct 29, 2024

2024-25 “Think, Collaborate & Do” Awards Announced

2024-2025 Faculty Awards: 2024-2025 Student Awards: Congratulations to all our awardees! 

Feb 5, 2024

Ashley Brown Appointed Co-Director of CMI

The Comparative Medicine Institute is pleased to announce that Dr. Ashley Brown, Associate Professor and University Faculty Scholar in the NC State/UNC Joint Department of Biomedical Engineering, has been appointed as co-director, alongside Dr. Jorge Piedrahita.  Dr. Brown’s research focuses on developing novel soft materials for a variety of biomedical applications including wound healing, hemostasis, and… 

Aug 30, 2022

Announcing the 2022 Ideation Awardees

Faculty Awards Defining the role of TRPV1 neurons as regulators of radiosensitivity in head and neck cancer PIs: Santosh Mishra & Michael Nolan Funded by CMI A Canine Cancer Moonshot: Belka and Strelka for Canine CAR T Cells PIs: Yevgeny Brudno & Christopher Mariani Funded by CMI & GGA with CATALYZE entrepreneurial supplement A Multimodal… 

Apr 29, 2021

Brudno receives $2.8 million from NCI to fund CAR-T advancements

Yevgeny Brudno, Assistant Professor of Biomedical Engineering and member of the Chemistry of Life Program and Functional Tissue Engineering Group within the Comparative Medicine Institute has received a 7-year, $2.8 million R37 grant from NCI entitled “Biomaterial Scaffolds for Ex-Vivo and In-Situ CAR-T Cell Production”. CAR-T cell therapy drafts a patient’s own cells to target and kill tumors. This therapy combines…